399 related articles for article (PubMed ID: 16243814)
1. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
2. Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy.
Bobola MS; Emond MJ; Blank A; Meade EH; Kolstoe DD; Berger MS; Rostomily RC; Silbergeld DL; Spence AM; Silber JR
Clin Cancer Res; 2004 Dec; 10(23):7875-83. PubMed ID: 15585620
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
4. Apurinic/apyrimidinic endonuclease is inversely associated with response to radiotherapy in pediatric ependymoma.
Bobola MS; Jankowski PP; Gross ME; Schwartz J; Finn LS; Blank A; Ellenbogen RG; Silber JR
Int J Cancer; 2011 Nov; 129(10):2370-9. PubMed ID: 21207372
[TBL] [Abstract][Full Text] [Related]
5. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress.
Silber JR; Bobola MS; Blank A; Schoeler KD; Haroldson PD; Huynh MB; Kolstoe DD
Clin Cancer Res; 2002 Sep; 8(9):3008-18. PubMed ID: 12231548
[TBL] [Abstract][Full Text] [Related]
6. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
8. Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo.
Wang D; Zhong ZY; Li MX; Xiang DB; Li ZP
Cancer Sci; 2007 Dec; 98(12):1993-2001. PubMed ID: 17892509
[TBL] [Abstract][Full Text] [Related]
9. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
[TBL] [Abstract][Full Text] [Related]
12. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
13. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo.
Xiang DB; Chen ZT; Wang D; Li MX; Xie JY; Zhang YS; Qing Y; Li ZP; Xie J
Cancer Gene Ther; 2008 Oct; 15(10):625-35. PubMed ID: 18535621
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.
Grotzer MA; Geoerger B; Janss AJ; Zhao H; Rorke LB; Phillips PC
Med Pediatr Oncol; 2001 Feb; 36(2):268-73. PubMed ID: 11452934
[TBL] [Abstract][Full Text] [Related]
15. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas.
Bobola MS; Blank A; Berger MS; Stevens BA; Silber JR
Clin Cancer Res; 2001 Nov; 7(11):3510-8. PubMed ID: 11705870
[TBL] [Abstract][Full Text] [Related]
16. Human glioma cell sensitivity to the sequence-specific alkylating agent methyl-lexitropsin.
Bobola MS; Varadarajan S; Smith NW; Goff RD; Kolstoe DD; Blank A; Gold B; Silber JR
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):612-20. PubMed ID: 17255284
[TBL] [Abstract][Full Text] [Related]
17. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
19. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
[TBL] [Abstract][Full Text] [Related]
20. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
